Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 11, 2026
Back to directoryFDA-cleared cardiac AI solution that analyzes routine chest CTs for coronary artery calcium and returns calcium scoring or detection-category outputs for clinician review.
Imaging programs that want opportunistic cardiovascular risk detection from existing CT studies while preserving radiologist review, cardiology follow-up, and local preventive-care protocols.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Nanox.AI HealthCCSng as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as regulated radiological post-processing software; match use to the exact cleared HealthCCSng version, patient age, CT study type, output type, radiologist review boundary, and non-standalone decision language. |
|---|---|
| Privacy | Review DICOM routing, cloud processing, PACS and EMR interfaces, PHI and metadata retention, support access, audit logging, cybersecurity materials, BAA terms, and model-update governance before routing production scans. |
| Evidence | Validate against local CT protocols, scanner vendors, calcium prevalence, radiology reporting patterns, cardiology follow-up capacity, false-positive burden, missed disease, and patient outcomes rather than relying only on clearance or vendor case studies. |
| Workflow | Best governed as opportunistic imaging detection feeding radiologist-reviewed reports and predefined cardiovascular follow-up pathways, with ownership across radiology, cardiology, primary care, quality, privacy, and IT. |
Nanox describes its AI Cardiac Solution as FDA 510(k)-cleared and CE-marked software that analyzes routine non-contrast, non-ECG-gated chest CT scans, measures and visualizes coronary calcified plaque, and integrates output into radiology reports and EMR systems. FDA 510(k) K241440 describes HealthCCSng as post-processing software for routine non-gated, non-contrast CT studies that include the entire heart in adults age 30 to 85, and states results are not intended for standalone risk attribution or clinical decision-making.
Not for: Standalone coronary risk attribution, autonomous clinical decision-making, diagnosis without clinician assessment, unsupported CT protocols, patients outside the cleared age and study scope, or deployments without CAC follow-up governance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.